Life science is a broadening field with multiple applications. Biovisory's strategic support extends to the full spectrum of life science industries comprising
Pharma, Medtech, Diagnostics, CDMO, API manufacturers and investors (PE/VC). Take a look at past projects and understand Biovisory's wide spectrum of knowledge.
Examples of past projects:
-
Technology scouting for a global pharma
player
-
Externalization strategy for Global top 5
diagnostics Company
Biovisory assessed exit options for a broad application lab technology.
-
Sell-side CDD for an international innovation leader in microbiology diagnostics
Biovisory delivered a detailed CDD
report including market performance analysis.
-
Development strategy for US pharma company
Biovisory performed a EU market entry study for a compound in psychiatry including clinical
development planning.
-
Market assessment for
internationally leading CDMO
Biovisory analyzed the market for fixed-dose-combinations in diabetes care and evaluated an investment strategy for a new manufacturing
plant.
-
Commercial analysis for leading
API manufacturer for high-potent drugs
Biovisory delivered a comprehensive global market assessment and competitive landscaping for a portfolio of high-potent APIs and a newly acquired GMP manufacturing
site.
-
Multiple buy-side CDDs for international private equity companies
Biovisory supported
numerous CDDs in various Life Science areas e.g. CDMOs, CROs, genetic diagnostics, hospitals.